Our R&D Focus

Our R&D focus is on developing cell therapies for diabetes, cancer, neuronal diseases, and blood diseases.

 

Collaborations with biopharma and other research and development organizations form a core component of our strategy to accelerate the development of cell therapies. We pursue strategic partnerships for cell validation, pre-clinical testing, and therapy development. We view ourselves as the front-end provider of the cellular material and enabler of successful clinical programs.

 

For example, we currently pursue collaborations with the Advanced Regenerative Manufacturing Institute (ARMI) in the area of neuronal cells, blood, and Covid-19.

Our Cell Therapy Programs

Diabetes

Bone Marrow Failure

Blood Diseases

Huntington's Disease

Parkinson's Disease

Other Programs

R&D Products

COVID-19